Marc Scherlinger: Uncovering the Immuno-Inflammatory Functions of Platelets at EULAR 2026
Marc Scherlinger, Head of Clinic – INSERM Bettencourt, Rheumatology, Strasbourg University Hospital, shared on LinkedIn:
”Today, I had the honour of presenting an update on the role of blood platelets in autoimmune and inflammatory diseases at the European Congress of EULAR – European Alliance of Associations for Rheumatology.
For a long time, platelets were considered only as actors in hemostasis, but now appear to be major players in inflammation.
In these pathologies, they contribute in particular to the link between chronic inflammation and the increase in cardiovascular and thrombotic risk.
Our work, supported by FOREUM – Foundation for Research in Rheumatology and Inserm, sheds light on these immuno-inflammatory functions of platelets and paves the way for new therapeutic approaches to improve the management of patients with chronic inflammatory diseases, such as systemic lupus.
A big thank you to the organizers, including Professor Christophe Richez for this opportunity for scientific exchange around these clinical and translational issues.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios AndreadisÖ‰ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI